Cargando...
B7-H3/CD276: An Emerging Cancer Immunotherapy
Immunotherapy aiming at suppressing tumor development by relying on modifying or strengthening the immune system prevails among cancer treatments and points out a new direction for cancer therapy. B7 homolog 3 protein (B7-H3, also known as CD276), a newly identified immunoregulatory protein member o...
Guardado en:
| Publicado en: | Front Immunol |
|---|---|
| Autores principales: | , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8326801/ https://ncbi.nlm.nih.gov/pubmed/34349762 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.701006 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|